ON THIS PAGE
Jeffrey Roberts and the IBS Patient Support Group have provided in-person testimony to the U.S. Food and Drug Administration (FDA). The IBS Patient Support Group has shared the perspective of Irritable Bowel Syndrome (IBS) and other functional GI and motility disorder (FGID) patients with several FDA committees. We bring the patient perspective to committees in the regulatory decision making process so that they can be directly informed as to how decisions affect patients.
Jeffrey attends Digestive Disease Week (DDW), the annual scientific and medical research conference, annually as well as the American College of Gastroenterology (ACG) scientific conference.
Jeffrey Roberts provided in-person testimony to the U.S. Food and Drug Administration (FDA) on the following dates:
Last updated on Jul 15, 2021